Target intelligence / Profile preview

Long intergenic non-protein coding RNA 242 (LINC00242)

Target
LINC00242
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA
01

Overview

Long intergenic non-protein coding RNA 242 (LINC00242) is a long non-coding RNA (lncRNA) categorized specifically as a long intergenic non-coding RNA, meaning it is transcribed from genomic regions not overlapping protein-coding genes[1]. LINC00242 functions in part by modulating gene expression and has been shown to play an oncogenic role in gastric cancer by promoting cell proliferation and aerobic glycolysis through the LINC00242/miR-1-3p/G6PD axis; it acts as a molecular sponge for miR-1-3p, thereby permitting increased expression of G6PD and promoting metabolic reprogramming in cancer cells[2]. LINC00242 is not a protein, receptor, enzyme, or traditional drug target, but is significant for its function in cancer progression and possible value as a biomarker. Its dysregulation is associated with worse outcomes in cancer models, supporting its emerging significance in tumor biology[2].

Other names
LINC00242C6orf122NCRNA00242FLJ31451dJ266L20.5Putative uncharacterized protein encoded by LINC00242
02

Mechanism of action

Regulation through the LINC00242/miR-1-3p/G6PD axis; LINC00242 acts as a molecular sponge for miR-1-3p, thereby relieving miR-1-3p-mediated suppression of G6PD expression, affecting proliferation and glycolysis in gastric cancer cells[2]

03

Biological functions

Regulation of gene expressionModulation of cancer cell proliferationRegulation of aerobic glycolysis (Warburg effect)Competing endogenous RNA (ceRNA) activity (sponges miRNA)
04

Disease associations

Cancer (notably gastric cancer)Tumor progression
05

Biomarkers

Potential biomarker for gastric cancer progression and tumor burden[2]

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 242 (LINC00242).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 242 (LINC00242).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call